カテゴリ： GlobalData, 医療/バイオ

変形性関節症治療薬の世界市場：治験レビュー

◆英語タイトル：Osteoarthritis Global Clinical Trials Review, H2, 2019
◆商品コード：GDT20FB0019
◆発行会社（リサーチ会社）：GlobalData
◆発行日：2019年10月
◆ページ数：1578
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥275,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD5,000 ⇒換算￥550,000見積依頼/購入/質問フォーム
Enterprisewide Price（複数事業所内共有可）USD7,500 ⇒換算￥825,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

 【レポートの概要】

Osteoarthritis Global Clinical Trials Review, H2, 2019
Summary

GlobalData’s clinical trial report, “Osteoarthritis Global Clinical Trials Review, H2, 2019″ provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) clinical trials scenario. This report provides top line data relating to the clinical trials on End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Osteoarthritis to Musculoskeletal Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Osteoarthritis to Musculoskeletal Disorders Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Osteoarthritis Therapeutics Clinical Trials 35
Prominent Drugs 37
Clinical Trial Profile Snapshots 38
Appendix 1605
Abbreviations 1605
Definitions 1605
Research Methodology 1606
Secondary Research 1607
About GlobalData 1607
Contact Us 1607
Source 1608

List of Tables
Osteoarthritis Therapeutics, Global, Clinical Trials by Region, 2019* 7
Osteoarthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Osteoarthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Osteoarthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11
Osteoarthritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12
Osteoarthritis Therapeutics Clinical Trials, North America, Top Countries, 2019* 13
Osteoarthritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 14
Osteoarthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 15
Proportion of Osteoarthritis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2019* 17
Osteoarthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Osteoarthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of Osteoarthritis to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2019* 22
Osteoarthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23
Osteoarthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
Osteoarthritis Therapeutics, Global, Clinical Trials by Phase, 2019* 26
Osteoarthritis Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 27
Osteoarthritis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29
Osteoarthritis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
Osteoarthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31
Osteoarthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 32
Osteoarthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34
Osteoarthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36
Osteoarthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37

List of Figures
Osteoarthritis Therapeutics, Global, Clinical Trials by Region (%), 2019* 7
Osteoarthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8
Osteoarthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Osteoarthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11
Osteoarthritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12
Osteoarthritis Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13
Osteoarthritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 14
Osteoarthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 15
Proportion of Osteoarthritis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2019* 16
Osteoarthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Osteoarthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Osteoarthritis to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2019* 21
Osteoarthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23
Osteoarthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24
Osteoarthritis Therapeutics, Global, Clinical Trials by Phase (%), 2019* 26
Osteoarthritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 27
Osteoarthritis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28
Osteoarthritis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
Osteoarthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31
Osteoarthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 32
Osteoarthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 33
Osteoarthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 35
Osteoarthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37
GlobalData Methodology 1606

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[変形性関節症治療薬の世界市場：治験レビュー]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 骨折治療薬の世界市場：治験レビュー
    GDT20FB0022 / GlobalData / 2019年10月 / ...Bone Fracture Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Bone Fracture Global Clinical Trials Review, H2, 2019" provides an overview of Bone Fracture clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Fracture . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials)....
  2. 脛骨プラトー骨折治療薬の世界市場：治験レビュー
    GDT20FB0020 / GlobalData / 2019年10月 / ...Tibial Plateau Fracture Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Tibial Plateau Fracture Global Clinical Trials Review, H2, 2019" provides an overview of Tibial Plateau Fracture clinical trials scenario. This report provides top line data relating to the clinical trials on Tibial Plateau Fracture . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on...
  3. サルコペニア治療薬の世界市場：治験レビュー
    GDT20FB0055 / GlobalData / 2019年12月 / ...Sarcopenia Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Sarcopenia Global Clinical Trials Review, H2, 2019" provides an overview of Sarcopenia clinical trials scenario. This report provides top line data relating to the clinical trials on Sarcopenia . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports...
  4. 筋骨格痛治療薬の世界市場：治験レビュー
    GDT20FB0003 / GlobalData / 2019年12月 / ...Musculoskeletal Pain Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Musculoskeletal Pain Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Musculoskeletal Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Musculoskeletal Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials)....
  5. ビタミンD欠乏症治療薬の世界市場：治験レビュー
    GDT20FB0104 / GlobalData / 2020年1月 / ...Vitamin D Deficiency Disorders Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Vitamin D Deficiency Disorders Global Clinical Trials Review, H1, 2020" provides an overview of Vitamin D Deficiency Disorders Clinical trials scenario. This report provides top line data relating to the clinical trials on Vitamin D Deficiency Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
  6. 先端巨大症治療薬の世界市場：治験レビュー
    GDT20FB0054 / GlobalData / 2019年12月 / ...Acromegaly Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Acromegaly Global Clinical Trials Review, H2, 2019" provides an overview of Acromegaly clinical trials scenario. This report provides top line data relating to the clinical trials on Acromegaly . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports...
  7. 線維症治療薬の世界市場：治験レビュー
    GDT20FB0074 / GlobalData / 2019年12月 / ...Fibrosis Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Fibrosis Global Clinical Trials Review, H2, 2019" provides an overview of Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Fibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  8. メタボリックシンドローム治療薬の世界市場：治験レビュー
    GDT20FB0114 / GlobalData / 2020年1月 / ...Metabolic Syndrome Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Metabolic Syndrome Global Clinical Trials Review, H1, 2020" provides an overview of Metabolic Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials onMetabolic Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical...
  9. 熱性好中球減少症治療薬の世界市場：治験レビュー
    GDT20FB0043 / GlobalData / 2019年12月 / ...Febrile Neutropenia Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Febrile Neutropenia Global Clinical Trials Review, H2, 2019" provides an overview of Febrile Neutropenia clinical trials scenario. This report provides top line data relating to the clinical trials on Febrile Neutropenia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  10. 血液凝固治療薬の世界市場：治験レビュー
    GDT20FB0072 / GlobalData / 2019年12月 / ...Blood Coagulation Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Blood Coagulation Global Clinical Trials Review, H2, 2019" provides an overview of Blood Coagulation clinical trials scenario. This report provides top line data relating to the clinical trials on Blood Coagulation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆